An Open Label Study to Evaluate the Safety and Efficacy of Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Prior Treatment With Methotrexate.
Phase of Trial: Phase IV
Latest Information Update: 18 Aug 2017
At a glance
- Drugs Rituximab (Primary) ; Methotrexate; Methylprednisolone
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Roche
- 10 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Sep 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 Feb 2010 Status changed from active, no longer recruiting to recruiting as reported by Roche.